A randomized controlled trial of equivalence between pantoprazole and esomeprazole that does not have the power to conclude.
Madisch
A
A
Kuhlisch
E
E
Miehlke
S
S
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D064098:Esomeprazole / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D000077402:Pantoprazole; D016032:Randomized Controlled Trials as Topic; D013454:Sulfoxides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D013454:Sulfoxides; D000077402:Pantoprazole; D064098:Esomeprazole